These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22370637)

  • 1. miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
    Catuogno S; Cerchia L; Romano G; Pognonec P; Condorelli G; de Franciscis V
    Oncogene; 2013 Jan; 32(3):341-51. PubMed ID: 22370637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
    Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P
    Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
    Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
    Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
    Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of miR-34c-3p and miR-34c-5p on SiHa cells proliferation apoptosis, migration and invasion.
    López JA; Alvarez-Salas LM
    Biochem Biophys Res Commun; 2011 Jun; 409(3):513-9. PubMed ID: 21600876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
    Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of microRNAs in drug-resistant ovarian cancer cells.
    Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
    Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).
    Wang Q; Zhong M; Liu W; Li J; Huang J; Zheng L
    Exp Lung Res; 2011 Sep; 37(7):427-34. PubMed ID: 21787234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis.
    Chatterjee A; Chattopadhyay D; Chakrabarti G
    Cell Signal; 2015 Feb; 27(2):189-203. PubMed ID: 25435430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression.
    Zang YS; Zhong YF; Fang Z; Li B; An J
    Cancer Gene Ther; 2012 Nov; 19(11):773-8. PubMed ID: 22996741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells.
    Jiang L; Huang Q; Chang J; Wang E; Qiu X
    Exp Lung Res; 2011 Sep; 37(7):387-98. PubMed ID: 21777146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of direct targets for the miR-17-92 cluster by proteomic analysis.
    Kanzaki H; Ito S; Hanafusa H; Jitsumori Y; Tamaru S; Shimizu K; Ouchida M
    Proteomics; 2011 Sep; 11(17):3531-9. PubMed ID: 21751348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathways and functional analysis of miRNA expression associated with paclitaxel-induced apoptosis in hepatocellular carcinoma cells.
    Yan H; Wang S; Yu H; Zhu J; Chen C
    Pharmacology; 2013; 92(3-4):167-74. PubMed ID: 24060847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.
    Li J; Chen Y; Zhao J; Kong F; Zhang Y
    Cancer Lett; 2011 May; 304(1):52-9. PubMed ID: 21354697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
    Sun Y; Bai Y; Zhang F; Wang Y; Guo Y; Guo L
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1483-9. PubMed ID: 20034472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of A549 lung cancer tumors by anti-miR-150 vector.
    Li YJ; Zhang YX; Wang PY; Chi YL; Zhang C; Ma Y; Lv CJ; Xie SY
    Oncol Rep; 2012 Jan; 27(1):129-34. PubMed ID: 21935578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.